Fairfax, Va., July 16, 2014The American Society for Radiation Oncology (ASTRO) has selected internationally renowned surgeon Angelita Habr-Gama, MD, PhD, as the 2014 Honorary Member, the highest honor ASTRO bestows on distinguished cancer researchers, scientists and leaders in disciplines other than radiation oncology, radiobiology or radiation physics. Dr. Habr-Gama will be inducted as the 2014 ASTRO Honorary Member during the Awards Ceremony on Tuesday, September 16, at ASTRO's 56th Annual Meeting, September 14-17, 2014, at Moscone Center in San Francisco.
ASTRO first awarded Honorary Membership in 1989. Including Dr. Habr-Gama, 31 individuals have been selected to receive Honorary Membership in ASTRO.
"Dr. Habr-Gama's extensive research in developing and promoting nonoperative treatment approaches for rectal cancer, including radiation therapy, is important to providing optimal cancer care for each patient's unique situation," said Colleen A.F. Lawton, MD, FASTRO, chair of ASTRO's Board of Directors. "Her continued study of additional treatment strategies and her emphasis on a change in the standards of care demonstrate her dedication to improving the lives of cancer patients worldwide. Thank you, Angelita, for your outstanding achievements."
Dr. Habr-Gama is internationally recognized for her work in developing and supporting selective nonoperative treatment approaches for rectal cancer. She has published 177 articles in peer-reviewed medical journals. Dr. Habr-Gama founded the Division of Coloproctology at the University of Sao Paulo School of Medicine, and has been a member of the Board of the Oncology Foundation of Sao Paulo since 1990.
In the late 1980s, Dr. Habr-Gama discovered that patients with rectal cancer who had received neoadjuvant chemoradiation therapy did not have residual cancer; however, the patients were still undergoing abdominal perineal resections.
"When we discovered this, I could n
|Contact: Michelle Kirkwood|
American Society for Radiation Oncology